143 related articles for article (PubMed ID: 29183962)
1. Intestinal lymphatic HDL miR-223 and ApoA-I are reduced during insulin resistance and restored with niacin.
Mangat R; Borthwick F; Haase T; Jacome M; Nelson R; Kontush A; Vine DF; Proctor SD
FASEB J; 2018 Mar; 32(3):1602-1612. PubMed ID: 29183962
[TBL] [Abstract][Full Text] [Related]
2. Effect of biliary diversion on rat mesenteric lymph apolipoprotein-I and high density lipoprotein.
Bearnot HR; Glickman RM; Weinberg L; Green PH; Tall AR
J Clin Invest; 1982 Jan; 69(1):210-7. PubMed ID: 6798073
[TBL] [Abstract][Full Text] [Related]
3. Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport.
Jin FY; Kamanna VS; Kashyap ML
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2020-8. PubMed ID: 9351367
[TBL] [Abstract][Full Text] [Related]
4. Intestinal assembly and secretion of highly dense/lipid-poor apolipoprotein B48-containing lipoprotein particles in the fasting state: evidence for induction by insulin resistance and exogenous fatty acids.
Guo Q; Avramoglu RK; Adeli K
Metabolism; 2005 May; 54(5):689-97. PubMed ID: 15877301
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins.
Qin B; Qiu W; Avramoglu RK; Adeli K
Diabetes; 2007 Feb; 56(2):450-61. PubMed ID: 17259391
[TBL] [Abstract][Full Text] [Related]
6. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
[TBL] [Abstract][Full Text] [Related]
7. Effects of niacin and chromium on the expression of ATP-binding cassette transporter A1 and apolipoprotein A-1 genes in HepG2 cells.
Siripurkpong P; Na-Bangchang K
J Nutr Biochem; 2009 Apr; 20(4):261-8. PubMed ID: 18602814
[TBL] [Abstract][Full Text] [Related]
8. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
Srivastava RA; Srivastava N; Averna M
Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of niacin.
Kamanna VS; Kashyap ML
Am J Cardiol; 2008 Apr; 101(8A):20B-26B. PubMed ID: 18375237
[TBL] [Abstract][Full Text] [Related]
10. Niacin promotes cholesterol efflux through stimulation of the PPARgamma-LXRalpha-ABCA1 pathway in 3T3-L1 adipocytes.
Wu ZH; Zhao SP
Pharmacology; 2009; 84(5):282-7. PubMed ID: 19797938
[TBL] [Abstract][Full Text] [Related]
11. Human intestinal lipoproteins. Studies in chyluric subjects.
Green PH; Glickman RM; Saudek CD; Blum CB; Tall AR
J Clin Invest; 1979 Jul; 64(1):233-42. PubMed ID: 221544
[TBL] [Abstract][Full Text] [Related]
12. Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus.
Pang J; Chan DC; Hamilton SJ; Tenneti VS; Watts GF; Barrett PH
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):427-32. PubMed ID: 24285582
[TBL] [Abstract][Full Text] [Related]
13. The novel selective PPARα modulator (SPPARMα) pemafibrate improves dyslipidemia, enhances reverse cholesterol transport and decreases inflammation and atherosclerosis.
Hennuyer N; Duplan I; Paquet C; Vanhoutte J; Woitrain E; Touche V; Colin S; Vallez E; Lestavel S; Lefebvre P; Staels B
Atherosclerosis; 2016 Jun; 249():200-8. PubMed ID: 27108950
[TBL] [Abstract][Full Text] [Related]
14. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
Staels B; Van Tol A; Fruchart JC; Auwerx J
Isr J Med Sci; 1996 Jun; 32(6):490-8. PubMed ID: 8682657
[TBL] [Abstract][Full Text] [Related]
15. High levels of human apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoprotein (HDL) particles comparable to human HDL3.
Walsh A; Ito Y; Breslow JL
J Biol Chem; 1989 Apr; 264(11):6488-94. PubMed ID: 2495286
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response.
Hennuyer N; Poulain P; Madsen L; Berge RK; Houdebine LM; Branellec D; Fruchart JC; Fiévet C; Duverger N; Staels B
Circulation; 1999 May; 99(18):2445-51. PubMed ID: 10318668
[TBL] [Abstract][Full Text] [Related]
17. Studies in genetically modified mice implicate maternal HDL as a mediator of fetal growth.
Rebholz SL; Melchior JT; Davidson WS; Jones HN; Welge JA; Prentice AM; Moore SE; Woollett LA
FASEB J; 2018 Feb; 32(2):717-727. PubMed ID: 28982731
[TBL] [Abstract][Full Text] [Related]
18. Elevation of tumor necrosis factor-alpha induces the overproduction of postprandial intestinal apolipoprotein B48-containing very low-density lipoprotein particles: evidence for related gene expression of inflammatory, insulin and lipoprotein signaling in enterocytes.
Qin B; Dawson H; Anderson RA
Exp Biol Med (Maywood); 2010 Feb; 235(2):199-205. PubMed ID: 20404035
[TBL] [Abstract][Full Text] [Related]
19. Isolation of high density lipoproteins from rat intestinal epithelial cells.
Magun AM; Brasitus TA; Glickman RM
J Clin Invest; 1985 Jan; 75(1):209-18. PubMed ID: 3965504
[TBL] [Abstract][Full Text] [Related]
20. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
Chan DC; Barrett PH; Ooi EM; Ji J; Chan DT; Watts GF
J Clin Endocrinol Metab; 2009 Mar; 94(3):989-97. PubMed ID: 19116237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]